Xencor reported $12.65M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
Amgen USD 2.86B 16.65B Jun/2026
Arrowhead Research USD 27.78M 2.97M Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Biogen USD 403.9M 45.4M Jun/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Cytokinetics USD 20.51M 4.2M Jun/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
J&J USD 9.22B 1.24B Jun/2026
Karyopharm Therapeutics USD 4.28M 276K Mar/2026
MacroGenics USD 3.44M 845K Jun/2026
Merck USD 3.83B 36M Jun/2026
Novartis USD 4.26B 64M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Xencor USD 12.65M 4.73M Jun/2026